Senior insider sale
EVP, CFO, Secy & Treas. at Y-MABS THERAPEUTICS, INC. — senior position signals high conviction
$722.0K
60K shares
What this filing means
KRUSE BO plans to sell 60K shares of Y-MABS THERAPEUTICS, INC. valued at approximately $722.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/30/2024ACC: 0001964306-24-000233
DirectorOfficer· EVP, CFO, Secy & Treas.
Since Sep 2018
60K
Shares to sell
$722.0K
Approx. market value
60K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of employee stock options
Broker assisted cashless exercise
5/30/2024
60KTotal acquired60K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/30/2024 | Exercise of employee stock options Broker assisted cashless exercise | 60K | — |
| Total | 60K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
60K
Market value
$722.0K
5/30/2024
Total
Units
60K
Value
$722.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/30/2024 | 60K | $722.0K | NASDAQ | Planned |
| Total | 60K | $722.0K | ||